A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease

Phase 4 Unknown 469 enrolled Jiangsu Hansoh Pharmaceutical Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

To assess the efficacy, safety and Population Pharmacokinetic (PPK) of morinidazole and sodium chloride injection with levofloxacin hydrochloride and sodium chloride injection sequential of levofloxacin hydrochloride tablets in women with pelvic inflammatory disease: An Open-Lable Multicenter Prospective Non-Randomized Trial

Timeline

Start: 2016-09
Primary completion: 2018-12
Completion: 2018-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	morinidazole	Small molecule	500 mg	Intravenous
Background	Levofloxacin	Small molecule	500 mg	Intravenous

A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease

Summary

Timeline

Drugs

Indications